Marlborough, MA-based Boston Sci will sell the BTG Specialty Pharmaceuticals business for $800 million in cash to Stark International Lux S.A.R.L., and SERB SAS.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,